lamotrigine 100 MG Oral Tablet [Subvenite]
RxNorm concept 2003796, branded drug (sbd). Prescribable name: Subvenite 100 MG Oral Tablet.
- RxCUI
- 2003796
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2003796 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Subvenite 100 MG Oral Tablet; lamoTRIgine 100 MG Oral Tablet [Subvenite]
Related concepts
- lamotrigine 100 MG (SCDC, consists of)
- lamotrigine 100 MG [Subvenite] (SBDC, consists of)
- {14 (lamotrigine 100 MG Oral Tablet [Subvenite]) / 84 (lamotrigine 25 MG Oral Tablet [Subvenite]) } Pack [Subvenite Green (for Patients Taking Carbamazepine, Phenytoin, Phenobarbital, or Primidone and Not Taking Valproate)] (BPCK, contained in)
- {7 (lamotrigine 100 MG Oral Tablet [Subvenite]) / 42 (lamotrigine 25 MG Oral Tablet [Subvenite]) } Pack [Subvenite Orange (for Patients Not Taking Carbamazepine, Phenytoin, Phenobarbital, Primidone, or Valproate)] (BPCK, contained in)
- Oral Tablet (DF, has dose form)
- Subvenite (BN, has ingredient)
- lamotrigine 100 MG Oral Tablet (SCD, tradename of)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 2003796 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2003796 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2003796. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.